"Iguratimod ameliorates bleomycin‐induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase‐9"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Iguratimod ameliorates bleomycin‐induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase‐9

To investigate the potential therapeutic efficacy of iguratimod (IGU) on bleomycin (BLM)‐induced pulmonary fibrosis in mice. Click to show full abstract

To investigate the potential therapeutic efficacy of iguratimod (IGU) on bleomycin (BLM)‐induced pulmonary fibrosis in mice.

Keywords: bleomycin induced; ameliorates bleomycin; pulmonary fibrosis; fibrosis mice; iguratimod ameliorates

Journal Title: International Journal of Rheumatic Diseases
Year Published: 2019

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
0

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended